Attenuated Familial Adenomatous Polyposis Treatment Market Size

Attenuated Familial Adenomatous Polyposis Treatment Market size is likely to expand at significant growth rate during the forecast period i.e., between 2024-2036. The growth of the market can be attributed to the growing number of incidences of colorectal diseases, inheritance of adenomatous polyposis coli (APC) gene and history of AFAP in someone’s family. It is calculated that the United States alone will have approximately 105,000 new cases of colon cancer and more than 45, 000 cases of rectal cancer by the end of 2021. Apart from these, growing technological advancements for developing effective treatment for the disease in developed nations and increasing prevalence of familial adenomatous polyposis (FAP) are also expected to drive growth to the market in the upcoming years. Furthermore, change in dietary preference, unhealthy lifestyle changes and lack of physical activities are projected to offer lucrative opportunities to the attenuated familial adenomatous polyposis treatment market in the near future.